On Friday, the US federal appeals court issued a stay on the Food and Drug Administration's ban on Juul products, following the company's request for an emergency administrative injunction. On Thursday, the regulatory agency took comprehensive action against the e-cigarette manufacturer, effectively shutting down its opportunity to enter the US market. According to court documents, the temporary ban is primarily to buy time until the court has adequate time to review the case, but it "should not be construed in any way as a ruling on the merits of the case.
The FDA took action against Juul after the company failed to provide sufficient evidence that their product is a safe alternative to tobacco. The regulatory agency stated that Juul's documents left them with "significant questions.
According to a report by The Wall Street Journal, Juul is considering filing for bankruptcy if it cannot overturn the FDA's order. Following the order, the Chief Regulatory Officer of Juul, Joe Murillo, stated that the company will seek a pause and plans to appeal the regulatory agency's decision.
Murillo stated, "In our application submitted over two years ago, we believed that we adequately described the toxicological characteristics of JUUL products, including comparisons with combustible cigarettes and other vapor products, and we believe that this data, along with all the evidence, met the statutory standard of 'appropriate for the protection of public health'.
Reynolds American and NJOY Holdings, competitors of Juul, will continue to sell their own vaporization electronic cigarettes in the United States. They have already received authorization from the Food and Drug Administration, while Juul, the largest influencer, was not authorized.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
